Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
about
Management of the adult with congenital adrenal hyperplasia.Ambulatory blood pressure and subclinical cardiovascular disease in patients with congenital adrenal hyperplasia: a preliminary report.Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyMetabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.Neonatal mass screening for 21-hydroxylase deficiency.Carotid Intima-Media Thickness Is Associated with Increased Androgens in Adolescents and Young Adults with Classical Congenital Adrenal HyperplasiaApproach to the patient: the adult with congenital adrenal hyperplasia.Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.The Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women
P2860
Q33960872-C56B2855-40F0-4606-9465-67EEA23B7A36Q35631493-1FF801F7-C174-43CB-8630-3159B9B8A3F0Q35916502-C713061B-AED2-45CC-8AEA-B0F2E3FCE680Q36436509-3652C63C-E346-48C1-B4E7-0A17E5BEBA9DQ36442459-6637CBDE-40BF-42FB-B75A-680D1C4F7AF7Q36535856-B8CE95FF-21F7-46A3-8B02-CEBF34448831Q36896732-41E1AFF1-C15D-479A-9EFC-1C44695E3F8CQ36981964-D90B8A60-BA69-4E6B-8C71-66D12AF80CBCQ38743172-664A47EB-3724-4DBB-9522-33EE9E1CE1BBQ58781170-744E386D-964D-4958-986F-9156A5619F2A
P2860
Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@en
type
label
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@en
prefLabel
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@ast
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@en
P2860
P356
P1476
Cardiovascular disease risk in ...... to 21-hydroxylase deficiency.
@en
P2093
Deborah P Merke
Mimi S Kim
P2860
P304
P356
10.1055/S-0029-1225259
P577
2009-06-15T00:00:00Z